Background In patients with heart failure, impairment of baroreflex function occurs early and
contributes to sympathetic activation, however, at present its prognostic role has not been …

This is a comment on" Assessment of baroreflex sensitivity has no prognostic value in
contemporary, optimally managed patients with mild-to-moderate heart failure with reduced …

Decreased sensitivity of cardiopulmonary and arterial baroreceptors has been hypothe
sized to sustain sympathetic activation in patients with heart failure. In the present inves …

Objectives We evaluated the prognostic value of cardiac baroreflex sensitivity (BRS) in
contemporary, optimally treated patients with mild‐to‐moderate heart failure with reduced …

The purpose of the present study was to assess the agreement between measurements of
baroreflex sensitivity (BRS) obtained by the Valsalva manoeuvre and by the phenylephrine …

Objectives: We sought to assess applicability, clinical correlates, and prognostic value of the
transfer function method for measuring baroreflex sensitivity (TF-BRS). Background …

Baroreflex sensitivity (BRS) is a powerful prognostic index in patients with previous
myocardial infarction [1] or heart failure (HF)[2, 3] and a potential therapeutic target [4, 5] …

Objectives No studies have compared the prognostic values of invasive (phenylephrine,
Phe) and noninvasive (transfer function) assessments of baroreflex sensitivity (BRS) …

Background In chronic heart failure (CHF), arterial baroreflex regulation of cardiac function is
impaired, leading to a reduction in the tonic restraining influence on the sympathetic nervous …

Objective: Several methods have been developed so far to estimate cardiac baroreflex
sensitivity (BRS) through the analysis of spontaneous fluctuations of systolic arterial …